Sinil Pharmaceutical (Korea) Price Prediction

012790 Stock  KRW 6,620  20.00  0.30%   
As of today, the value of RSI of Sinil Pharmaceutical's share price is approaching 33. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Sinil Pharmaceutical, making its price go up or down.

Oversold Vs Overbought

33

 
Oversold
 
Overbought
The successful prediction of Sinil Pharmaceutical's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Sinil Pharmaceutical Co, which may create opportunities for some arbitrage if properly timed.
Using Sinil Pharmaceutical hype-based prediction, you can estimate the value of Sinil Pharmaceutical Co from the perspective of Sinil Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Sinil Pharmaceutical to buy its stock at a price that has no basis in reality. In that case, they are not buying Sinil because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Sinil Pharmaceutical after-hype prediction price

    
  KRW 6620.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Sinil Pharmaceutical Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
5,7925,7947,282
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Sinil Pharmaceutical. Your research has to be compared to or analyzed against Sinil Pharmaceutical's peers to derive any actionable benefits. When done correctly, Sinil Pharmaceutical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Sinil Pharmaceutical.

Sinil Pharmaceutical After-Hype Price Prediction Density Analysis

As far as predicting the price of Sinil Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sinil Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sinil Pharmaceutical, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Sinil Pharmaceutical Estimiated After-Hype Price Volatility

In the context of predicting Sinil Pharmaceutical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sinil Pharmaceutical's historical news coverage. Sinil Pharmaceutical's after-hype downside and upside margins for the prediction period are 6,618 and 6,622, respectively. We have considered Sinil Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
6,620
6,620
After-hype Price
6,622
Upside
Sinil Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Sinil Pharmaceutical is based on 3 months time horizon.

Sinil Pharmaceutical Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Sinil Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sinil Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sinil Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.27 
1.56
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
6,620
6,620
0.00 
0.00  
Notes

Sinil Pharmaceutical Hype Timeline

Sinil Pharmaceutical is presently traded for 6,620on KOSDAQ of Korea. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Sinil is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.27%. %. The volatility of related hype on Sinil Pharmaceutical is about 0.0%, with the expected price after the next announcement by competition of 6,620. About 40.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Sinil Pharmaceutical had 26:25 split on the 28th of December 2022. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days.
Check out Sinil Pharmaceutical Basic Forecasting Models to cross-verify your projections.

Sinil Pharmaceutical Related Hype Analysis

Having access to credible news sources related to Sinil Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Sinil Pharmaceutical's future price movements. Getting to know how Sinil Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sinil Pharmaceutical may potentially react to the hype associated with one of its peers.

Sinil Pharmaceutical Additional Predictive Modules

Most predictive techniques to examine Sinil price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sinil using various technical indicators. When you analyze Sinil charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Sinil Pharmaceutical Predictive Indicators

The successful prediction of Sinil Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sinil Pharmaceutical Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sinil Pharmaceutical based on analysis of Sinil Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sinil Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sinil Pharmaceutical's related companies.

Story Coverage note for Sinil Pharmaceutical

The number of cover stories for Sinil Pharmaceutical depends on current market conditions and Sinil Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sinil Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sinil Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Sinil Pharmaceutical Short Properties

Sinil Pharmaceutical's future price predictability will typically decrease when Sinil Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sinil Pharmaceutical Co often depends not only on the future outlook of the potential Sinil Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sinil Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding11.2 M
Cash And Short Term Investments20.9 B

Complementary Tools for Sinil Stock analysis

When running Sinil Pharmaceutical's price analysis, check to measure Sinil Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinil Pharmaceutical is operating at the current time. Most of Sinil Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sinil Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinil Pharmaceutical's price. Additionally, you may evaluate how the addition of Sinil Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Valuation
Check real value of public entities based on technical and fundamental data